mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.2 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.051 |
0.2 |